Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Envelope icon Sign Up for E-mail Updates Teal square Text size:  a A A

Pancreatic Cancer: Screening

Release Date: February 2004

Recommendation Summary

Summary of Recommendation

(What's This?)
Asymptomatic Adults

The USPSTF recommends against routine screening for pancreatic cancer in asymptomatic adults using abdominal palpation, ultrasonography, or serologic markers. 

The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits

Rationale: The USPSTF found no evidence that screening for pancreatic cancer is effective in reducing mortality. There is a potential for significant harm due to the very low prevalence of pancreatic cancer, limited accuracy of available screening tests, the invasive nature of diagnostic tests, and the poor outcomes of treatment. As a result, the USPSTF concluded that the harms of screening for pancreatic cancer exceed any potential benefits.

Related Information for Consumers

There is no related information for consumers.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

Current as of: July 2015

Internet Citation: Final Update Summary: Pancreatic Cancer: Screening. U.S. Preventive Services Task Force. July 2015.

USPSTF Program Office   540 Gaither Road, Rockville, MD 20850